Fund shareholders of Gilead Sciences Inc
ISIN US3755581036 · United States · LEI 549300WTZWR07K8MNV44
- Fund shareholders
- 1,502
- Of which ETFs
- 400 1,102 other funds
- Value held
- 70.2B $ 11.2B SEK · 134.3M €
- Share of capital
- 41.5 % of 1.2B shares on Jul 31, 2026
1,502 funds hold this company. This table lists the 1,492 that declare it in a regulatory filing. The other 10 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Equity Index 500 Fund T. ROWE PRICE INDEX TRUST, INC. | 776,720 | 108.3M $ | 0.31 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 744,208 | 103.7M $ | 0.29 % | 0.06 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 743,690 | 97.3M $ | 0.26 % | 0.06 % | as of Apr 30, 2026 ↗ |
| VANGUARD MEGA CAP VALUE INDEX FUND VANGUARD WORLD FUND | 741,933 | 110.5M $ | 0.92 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 731,494 | 95.7M $ | 0.23 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 726,454 | 108.2M $ | 0.48 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 721,327 | 107.4M $ | 0.28 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Neuberger Large Cap Value Fund NEUBERGER BERMAN EQUITY FUNDS | 719,983 | 107.2M $ | 1.13 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 698,897 | 97.4M $ | 0.17 % | 0.06 % | as of Mar 31, 2026 ↗ |
| JPMorgan Active Growth ETF J.P. Morgan Exchange-Traded Fund Trust | 696,075 | 97M $ | 1.19 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Washington Mutual Investors Fund AMERICAN FUNDS INSURANCE SERIES | 678,610 | 94.6M $ | 0.83 % | 0.05 % | as of Mar 31, 2026 ↗ |
| BNY Mellon Dynamic Value Fund BNY Mellon Advantage Funds, Inc. | 675,616 | 100.6M $ | 0.89 % | 0.05 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) Value ETF SPDR SERIES TRUST | 671,974 | 93.7M $ | 0.29 % | 0.05 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 665,992 | 92.8M $ | 4.09 % | 0.05 % | as of Mar 31, 2026 ↗ |
| LORD ABBETT AFFILIATED FUND INC LORD ABBETT AFFILIATED FUND INC | 664,036 | 86.9M $ | 1.29 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Schwab Fundamental U.S. Large Company ETF SCHWAB STRATEGIC TRUST | 657,393 | 97.9M $ | 0.40 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Large-Cap Value ETF SCHWAB STRATEGIC TRUST | 654,261 | 97.5M $ | 0.62 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD FTSE SOCIAL INDEX FUND VANGUARD WORLD FUND | 651,463 | 97M $ | 0.39 % | 0.05 % | as of Feb 28, 2026 ↗ |
| NEOS Nasdaq-100(R) High Income ETF NEOS ETF Trust | 650,843 | 90.7M $ | 0.97 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 643,912 | 84.2M $ | 0.23 % | 0.05 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 639,683 | 83.7M $ | 2.99 % | 0.05 % | as of Apr 30, 2026 ↗ |
| JNL/Mellon Nasdaq 100 Index Fund JNL Series Trust | 613,604 | 85.5M $ | 0.97 % | 0.05 % | as of Mar 31, 2026 ↗ |
| U.S. High Relative Profitability Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 602,445 | 78.8M $ | 1.29 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 597,438 | 83.3M $ | 0.28 % | 0.05 % | as of Mar 31, 2026 ↗ |
| iShares Global Healthcare ETF iShares Trust | 596,340 | 83.1M $ | 2.29 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Nomura Large Cap Growth Fund IVY FUNDS | 588,755 | 82.1M $ | 1.40 % | 0.05 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 580,264 | 80.9M $ | 1.09 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 571,936 | 74.8M $ | 2.62 % | 0.05 % | as of Apr 30, 2026 ↗ |
| ClearBridge Value Fund Legg Mason Global Asset Management Trust | 570,000 | 74.6M $ | 1.79 % | 0.05 % | as of Apr 30, 2026 ↗ |
| iShares Core S&P U.S. Growth ETF iShares Trust | 567,983 | 79.2M $ | 0.30 % | 0.05 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - S&P 500 Index Account College Retirement Equities Fund | 565,914 | 78.9M $ | 0.31 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 560,000 | 78M $ | 0.38 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 552,124 | 82.2M $ | 0.17 % | 0.04 % | as of Feb 28, 2026 ↗ |
| iShares S&P 100 ETF iShares Trust | 547,866 | 76.4M $ | 0.43 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Victory Nasdaq-100 Index Fund Victory Portfolios III | 533,000 | 69.7M $ | 0.79 % | 0.04 % | as of Apr 30, 2026 ↗ |
| JNL/Mellon Healthcare Sector Fund JNL Series Trust | 531,704 | 74.1M $ | 2.90 % | 0.04 % | as of Mar 31, 2026 ↗ |
| iShares ESG Aware MSCI USA ETF iShares Trust | 531,588 | 79.2M $ | 0.50 % | 0.04 % | as of Feb 28, 2026 ↗ |
| JNL/T. Rowe Price Value Fund JNL Series Trust | 530,714 | 74M $ | 1.80 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 529,373 | 78.9M $ | 0.42 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Global X NASDAQ 100 Covered Call ETF GLOBAL X FUNDS | 520,505 | 68.1M $ | 0.82 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Six Circles Managed Equity Portfolio U.S. Unconstrained Fund SIX CIRCLES TRUST | 512,980 | 71.5M $ | 0.26 % | 0.04 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra QQQ ProShares Trust | 510,665 | 76.1M $ | 0.77 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 500,000 | 65.4M $ | 2.27 % | 0.04 % | as of Apr 30, 2026 ↗ |
| THE HARTFORD BALANCED INCOME FUND HARTFORD MUTUAL FUNDS, INC | 497,950 | 65.2M $ | 0.58 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 494,442 | 68.9M $ | 0.26 % | 0.04 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD EQUITY INCOME FUND HARTFORD MUTUAL FUNDS, INC | 492,538 | 64.4M $ | 1.31 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Nomura Growth and Income Fund Delaware Group Equity Funds IV | 488,145 | 68M $ | 3.77 % | 0.04 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Responsible Balanced Account College Retirement Equities Fund | 487,746 | 68M $ | 0.33 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Healthcare Swedbank Robur Fonder AB | 486,349 | 645.7M SEK | 4.54 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD S&P 500 GROWTH INDEX FUND VANGUARD ADMIRAL FUNDS | 482,445 | 71.9M $ | 0.33 % | 0.04 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P U.S. Value ETF iShares Trust | 480,683 | 67M $ | 0.28 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 476,809 | 62.4M $ | 0.14 % | 0.04 % | as of Apr 30, 2026 ↗ |
| MFS Research Fund MFS Series Trust V | 475,810 | 66.3M $ | 0.91 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 472,500 | 70.4M $ | 4.64 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 471,681 | 65.7M $ | 1.26 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Stock Selector Large Cap Value Fund Fidelity Devonshire Trust | 471,100 | 61.6M $ | 0.39 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Six Circles U.S. Unconstrained Equity Fund SIX CIRCLES TRUST | 471,093 | 65.7M $ | 0.21 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 467,000 | 620M SEK | 2.79 % | 0.04 % | as of Mar 31, 2026 ↗ |
| State Street Equity 500 Index II Portfolio STATE STREET INSTITUTIONAL INVESTMENT TRUST | 455,252 | 63.4M $ | 0.30 % | 0.04 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price U.S. Equity Research Fund T. Rowe Price U.S. Equity Research Fund, Inc. | 446,720 | 62.3M $ | 0.40 % | 0.04 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Global Equities Account College Retirement Equities Fund | 442,683 | 61.7M $ | 0.18 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Growth-Income Fund AMERICAN FUNDS INSURANCE SERIES | 430,961 | 60.1M $ | 0.15 % | 0.03 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 427,773 | 63.7M $ | 4.37 % | 0.03 % | as of Feb 27, 2026 ↗ |
| Swedbank Robur Aktiefond Pension Swedbank Robur Fonder AB | 426,844 | 566.7M SEK | 0.53 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 425,749 | 63.4M $ | 0.56 % | 0.03 % | as of Feb 28, 2026 ↗ |
| PSF PGIM Jennison Blend Portfolio Prudential Series Fund | 423,581 | 59M $ | 0.80 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Capital Group Core Balanced ETF Capital Group Core Balanced ETF | 416,794 | 58.1M $ | 1.08 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Schwab 1000 Index Fund SCHWAB INVESTMENTS | 396,350 | 51.9M $ | 0.24 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VIP Index 500 Portfolio Variable Insurance Products Fund II | 391,569 | 54.6M $ | 0.31 % | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares MSCI ACWI ETF iShares Trust | 391,023 | 51.2M $ | 0.16 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 390,092 | 54.4M $ | 14.63 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity New Millennium Fund Fidelity Mt. Vernon Street Trust | 380,300 | 56.6M $ | 1.04 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Enhanced Large Cap Core ETF Fidelity Covington Trust | 376,863 | 52.5M $ | 0.83 % | 0.03 % | as of Mar 31, 2026 ↗ |
| WisdomTree U.S. LargeCap Dividend Fund WisdomTree Trust | 374,337 | 52.2M $ | 0.92 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Nomura Core Equity Fund IVY FUNDS | 371,501 | 51.8M $ | 1.53 % | 0.03 % | as of Mar 31, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 370,354 | 491.7M SEK | 3.04 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Value Index Fund Fidelity Salem Street Trust | 370,184 | 48.4M $ | 0.36 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 370,176 | 48.4M $ | 0.24 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 368,999 | 48.3M $ | 4.66 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Stock Index Fund Northern Funds | 366,071 | 51M $ | 0.31 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Transamerica Large Cap Value TRANSAMERICA FUNDS | 359,159 | 47M $ | 1.93 % | 0.03 % | as of Apr 30, 2026 ↗ |
| JPMorgan U.S. Quality Factor ETF J.P. Morgan Exchange-Traded Fund Trust | 358,130 | 46.9M $ | 0.63 % | 0.03 % | as of Apr 30, 2026 ↗ |
| HARTFORD DIVIDEND AND GROWTH HLS FUND HARTFORD SERIES FUND INC | 353,098 | 49.2M $ | 1.54 % | 0.03 % | as of Mar 31, 2026 ↗ |
| JNL/Mellon S&P 500 Index Fund JNL Series Trust | 352,903 | 49.2M $ | 0.31 % | 0.03 % | as of Mar 31, 2026 ↗ |
| JPMorgan Nasdaq Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust | 351,797 | 49M $ | 0.14 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Value Index Fund TIAA-CREF Funds | 351,123 | 45.9M $ | 0.36 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Large Cap Index Fund Fidelity Concord Street Trust | 344,401 | 45.1M $ | 0.26 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Swedbank Robur Transfer 80 Swedbank Robur Fonder AB | 344,216 | 457M SEK | 0.48 % | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 337,528 | 47M $ | 0.28 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 337,004 | 44.1M $ | 3.90 % | 0.03 % | as of Apr 30, 2026 ↗ |
| JPMorgan Equity Focus ETF J.P. Morgan Exchange-Traded Fund Trust | 328,020 | 45.7M $ | 2.67 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Growth Fund TIAA-CREF Funds | 325,329 | 42.6M $ | 0.67 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth ETF Fidelity Covington Trust | 324,517 | 42.5M $ | 0.68 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares ESG Optimized MSCI USA ETF iShares Trust | 324,469 | 42.5M $ | 1.11 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Large Cap Value Index Fund Fidelity Salem Street Trust | 316,127 | 41.4M $ | 0.36 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity SAI U.S. Large Cap Index Fund Fidelity Salem Street Trust | 314,159 | 41.1M $ | 0.26 % | 0.03 % | as of Apr 30, 2026 ↗ |
| EQ/JPMorgan Growth Stock Portfolio EQ Advisors Trust | 306,345 | 42.7M $ | 1.60 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Value Discovery Fund Fidelity Puritan Trust | 302,238 | 39.5M $ | 1.04 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Schwab Fundamental U.S. Large Company Index Fund SCHWAB CAPITAL TRUST | 297,903 | 39M $ | 0.32 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Nuveen Large Cap Responsible Equity Fund TIAA-CREF Funds | 296,660 | 38.8M $ | 0.60 % | 0.02 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VanEck Biotech ETF VanEck ETF Trust | 14.63 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9.61 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 8.77 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.14 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.75 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 7.18 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6.48 % | as of Feb 28, 2026 ↗ |
| ProShares Nasdaq-100 Dorsey Wright Momentum ETF ProShares Trust | 5.67 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 5.42 % | as of Apr 30, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 5.40 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,336 | +84 | 506,124,423 | +3.8 % |
| 2026Q1 | 1,252 | +9 | 487,373,217 | +4.1 % |
| 2025Q4 | 1,243 | +10 | 468,305,734 | -2.6 % |
| 2025Q3 | 1,233 | +63 | 481,041,654 | -1.7 % |
| 2025Q2 | 1,170 | +100 | 489,169,265 | -2.9 % |
| 2025Q1 | 1,070 | +12 | 503,775,731 | +0.8 % |
| 2024Q4 | 1,058 | +35 | 499,619,246 | +0.5 % |
| 2024Q3 | 1,023 | -35 | 497,084,977 | -0.4 % |
| 2024Q2 | 1,058 | -30 | 498,997,563 | -0.2 % |
| 2024Q1 | 1,088 | -47 | 500,069,973 | -0.5 % |
| 2023Q4 | 1,135 | 502,399,825 |
Institutional managers
2,285 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 119,010,973 | 16.6B $ | as of Mar 31, 2026 |
| FMR LLC | 71,906,290 | 10B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 59,858,585 | 8.3B $ | as of Mar 31, 2026 |
| Capital World Investors | 41,283,933 | 5.8B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 33,992,410 | 4.6B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 29,726,052 | 4.1B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 27,127,533 | 3.8B $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 26,248,108 | 3.7M $ | as of Mar 31, 2026 |
| Dodge & Cox | 24,250,826 | 3.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 23,299,295 | 3.2B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 19,978,936 | 2.8B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 15,526,336 | 2.2B $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 15,053,151 | 2.1B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 13,820,379 | 1.9B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 13,537,991 | 1.9B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 13,199,103 | 1.8B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 11,065,214 | 1.5B $ | as of Mar 31, 2026 |
| Amundi | 10,539,111 | 1.5B $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 10,464,889 | 1.5B $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8,181,780 | 1.1B $ | as of Mar 31, 2026 |
| Nuveen, LLC | 7,833,564 | 1.1B $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 7,722,929 | 1.1B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 7,287,230 | 1B $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 6,628,441 | 923.8M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 6,281,609 | 909.7M $ | as of Mar 31, 2026 |
Declared shareholders of Gilead Sciences Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.51 % | 93,327,127 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Gilead Sciences Inc
288 funds declare 1,016 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Gilead Sciences Inc". https://titelia.com/en/stocks/gilead-sciences-inc-US3755581036